Cargando…
ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256994/ https://www.ncbi.nlm.nih.gov/pubmed/35814382 http://dx.doi.org/10.3389/fonc.2022.918778 |
_version_ | 1784741238057992192 |
---|---|
author | Yue, Hanxun Hu, Zenan Hu, Rui Guo, Zeying Zheng, Ya Wang, Yuping Zhou, Yongning |
author_facet | Yue, Hanxun Hu, Zenan Hu, Rui Guo, Zeying Zheng, Ya Wang, Yuping Zhou, Yongning |
author_sort | Yue, Hanxun |
collection | PubMed |
description | Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy. |
format | Online Article Text |
id | pubmed-9256994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92569942022-07-07 ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism Yue, Hanxun Hu, Zenan Hu, Rui Guo, Zeying Zheng, Ya Wang, Yuping Zhou, Yongning Front Oncol Oncology Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy. Frontiers Media S.A. 2022-06-22 /pmc/articles/PMC9256994/ /pubmed/35814382 http://dx.doi.org/10.3389/fonc.2022.918778 Text en Copyright © 2022 Yue, Hu, Hu, Guo, Zheng, Wang and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Yue, Hanxun Hu, Zenan Hu, Rui Guo, Zeying Zheng, Ya Wang, Yuping Zhou, Yongning ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism |
title | ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism |
title_full | ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism |
title_fullStr | ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism |
title_full_unstemmed | ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism |
title_short | ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism |
title_sort | aldh1a1 in cancers: bidirectional function, drug resistance, and regulatory mechanism |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256994/ https://www.ncbi.nlm.nih.gov/pubmed/35814382 http://dx.doi.org/10.3389/fonc.2022.918778 |
work_keys_str_mv | AT yuehanxun aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism AT huzenan aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism AT hurui aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism AT guozeying aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism AT zhengya aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism AT wangyuping aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism AT zhouyongning aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism |